High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial

Abstract: JTUMED916_proof ■ 13 May 2022 ■ 1/7 Journal of Taibah University Medical Sciences (xxxx) xxx(xxx), xxx Taibah University Journal of Taibah University Medical Sciences www.sciencedirect.com 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 Original Article High dose melatonin as an adjuvant therapy in intubated patients with Q2 COVID-19: A randomized clinical trial Nafiseh Alizadeh a, Mehrnoush Dianatkhah b, Yousef Alimohamadi c, Hazhir Moradi d, Samaneh Akbarpour e, Majid Akrami f, Fariba Mansouri g, Neda Faraji g, Zahra Rezaie h, i i, Q3 Mahboubeh Alizadeh and Hadiseh Hosamirudsari * Q18 a Department of Pharmaceutical Care, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran Department of Clinical Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran c Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran Q4 d Medical School, Isfahan University of Medical Sciences, Isfahan, Iran Q5 e Occupational Sleep Research Center, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran f Department of Anesthesiology, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran g Department of Internal Medicine, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran h Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran i Department of Infectious Diseases, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran b Received 13 February 2022; revised 11 April 2022; accepted 28 April 2022; Available online - - - ‫ﺍﻟﻤﻠﺨﺺ‬ ‫ ﺍﻟﻤﻼﻳﻴﻦ ﻣﻦ ﺍﻟﻨﺎﺱ ﻓﻲ ﺟﻤﻴﻊ ﺃﻧﺤﺎﺀ‬19-‫ ﺃﺻﺎﺑﺖ ﺟﺎﺋﺤﺔ ﻛﻮﻓﻴﺪ‬:‫ﺃﻫﺪﺍﻑ ﺍﻟﺒﺤﺚ‬ ‫ ﻣﻦ ﺍﻟﻤﻌﺮﻭﻑ ﺃﻥ ﺟﺮﻋﺔ‬.‫ ﺗﺮﺟﻊ ﺍﻟﻮﻓﻴﺎﺕ ﺃﺳﺎﺳﺎ ﻟﺤﺎﻟﺔ ﺍﻻﻟﺘﻬﺎﺏ ﻭﻣﻀﺎﻋﻔﺎﺗﻪ‬.‫ﺍﻟﻌﺎﻟﻢ‬ ‫ ﻗﻴﻤﺖ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﺟﺮﻋﺔ‬.‫ﻋﺎﻟﻴﺔ ﻣﻦ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﺗﻌﺘﺒﺮ ﻋﺎﻣﻼ ﻣﻀﺎﺩﺍ ﻟﻼﻟﺘﻬﺎﺑﺎﺕ‬ ‫ﻋﺎﻟﻴﺔ ﻣﻦ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﻛﻌﻼﺝ ﻣﺴﺎﻋﺪ ﻓﻲ ﺍﻟﺤﺎﻻﺕ ﺍﻟﺤﺮﺟﺔ ﻟﻠﻤﺮﺿﻰ ﺍﻟﻤﺼﺎﺑﻴﻦ‬ .19-‫ﺑﻌﺪﻭﻯ ﻛﻮﻓﻴﺪ‬ ‫ ﻣﻠﻎ‬21 ‫ ﺃﺟﺮﻳﻨﺎ ﺗﺠﺮﺑﺔ ﺳﺮﻳﺮﻳﺔ ﻋﺸﻮﺍﺋﻴﺔ ﻣﺰﺩﻭﺟﺔ ﺍﻟﺘﻌﻤﻴﺔ ﻟﺠﺮﻋﺔ‬:‫ﻃﺮﻕ ﺍﻟﺒﺤﺚ‬ ‫ ﺗﻢ‬.19-‫ ﻣﺮﻳﻀﺎ ﻛﻮﻓﻴﺪ‬67 ‫ﻣﻦ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﻓﻲ ﺍﻟﻴﻮﻡ ﻣﻘﺎﺭﻧﺔ ﻣﻊ ﺩﻭﺍﺀ ﻭﻫﻤﻲ ﺑﻴﻦ‬ ‫ ﺍﻟﻤﻮﺛﻘﺔ‬19-‫ ﻋﺎﻣﺎ ﻭﺍﻟﻤﺼﺎﺑﻴﻦ ﺑﻌﺪﻭﻯ ﻛﻮﻓﻴﺪ‬18 ‫ﺍﻟﺘﺴﺠﻴﻞ ﻟﻠﻤﺮﺿﻰ ﺍﻷﻛﺒﺮ ﻣﻦ‬ ‫ ﺍﺳﺘﻤﺮ‬.‫ﻭﺍﻟﺬﻳﻦ ﺗﻢ ﺇﺩﺧﺎﻟﻬﻢ ﺇﻟﻰ ﻭﺣﺪﺓ ﺍﻟﻌﻨﺎﻳﺔ ﺍﻟﻤﺮﻛﺰﺓ ﻭﺧﻀﻌﻮﺍ ﻟﺘﻬﻮﻳﺔ ﻣﻴﻜﺎﻧﻴﻜﻴﺔ‬ .‫ﺇﻋﻄﺎﺀ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﻭﺍﻟﻌﻼﺝ ﺍﻟﻮﻫﻤﻲ ﻟﻤﺪﺓ ﺧﻤﺴﺔ ﺃﻳﺎﻡ ﻣﻦ ﺧﻼﻝ ﺃﻧﺒﻮﺏ ﺃﻧﻔﻲ ﻣﻌﺪﻱ‬ ‫ ﻭﺍﻟﺘﻐﻴﺮﺍﺕ ﻓﻲ‬،‫ ﻭﻣﺪﺓ ﺍﻟﺘﻬﻮﻳﺔ ﺍﻟﻤﻴﻜﺎﻧﻴﻜﻴﺔ‬،‫ﻛﺎﻧﺖ ﺍﻟﻨﺘﺎﺋﺞ ﺍﻟﺮﺋﻴﺴﻴﺔ ﻣﻌﺪﻝ ﺍﻟﻮﻓﻴﺎﺕ‬ .‫ ﻭﻣﺴﺘﻮﻳﺎﺕ ﺍﻟﺒﺮﻭﺗﻴﻦ ﺍﻟﻤﺘﻔﺎﻋﻞ ﺳﻲ‬،‫ﻣﺆﺷﺮﺍﺕ ﺍﻷﻭﻛﺴﺠﻴﻦ‬ ‫ ﻟﻢ ﻳﻜﻦ ﻫﻨﺎﻙ ﻓﺮﻕ ﺟﻮﻫﺮﻱ ﻓﻲ ﺍﻟﻮﻓﻴﺎﺕ ﻭﻣﺪﺓ ﺍﻟﺘﻬﻮﻳﺔ ﺍﻟﻤﻴﻜﺎﻧﻴﻜﻴﺔ ﺑﻴﻦ‬:‫ﺍﻟﻨﺘﺎﺋﺞ‬ ‫ ﺍﻟﻤﺘﻮﺳﻂ )
ﺍﻻﻧﺤﺮﺍﻑ‬،‫ ﺃﻳﺎﻡ ﻣﻦ ﺍﻟﺘﺪﺧﻞ‬5 ‫ ﺑﻌﺪ‬.‫ﻣﺠﻤﻮﻋﺎﺕ ﺍﻟﺘﺤﻜﻢ ﻭﺍﻟﺘﺪﺧﻞ‬ * Corresponding address: Department of Infectious Disease, Baharloo Hospital, Tehran University of Medical Sciences, Behdari Q6 Street, Railway Square, Tehran, Iran. E-mail: h-hosami@sina.tums.ac.ir (H. Hosamirudsari) Peer review under responsibility of Taibah University. Production and hosting by Elsevier
) 47.28 ‫ﺍﻟﻤﻌﻴﺎﺭﻱ( ﻟـﻠﺒﺮﻭﺗﻴﻦ ﺍﻟﻤﺘﻔﺎﻋﻞ ﺳﻲ ﻭ ﻋﺪﺩ ﺍﻟﺼﻔﺎﺋﺢ ﺍﻟﺪﻣﻮﻳﺔ ﻛﺎﻥ‬ ‫ ﻣﻴﻜﺮﻭﻟﺘﺮ ﻓﻲ ﻣﺠﻤﻮﻋﺔ‬/  1000 (87.13
) 195.73 ‫ ﻟﺘﺮ ﻭ‬/ ‫( ﻣﻠﻐﻢ‬38.86 /  1000 (68.03
) 149.62 ‫ ﻟﺘﺮ ﻭ‬/ ‫( ﻣﻠﻐﻢ‬48.02
) 75.52 ‫ﺍﻟﺘﺪﺧﻞ ﻭ‬ .‫ﻣﻴﻜﺮﻭﻟﺘﺮ ﻓﻲ ﻣﺠﻤﻮﻋﺔ ﺍﻟﺘﺤﻜﻢ ﻋﻠﻰ ﺍﻟﺘﻮﺍﻟﻲ‬ 19-‫ ﺍﺭﺗﺒﻂ ﺗﻨﺎﻭﻝ ﺟﺮﻋﺎﺕ ﻋﺎﻟﻴﺔ ﻣﻦ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﻓﻲ ﻣﺮﺿﻰ ﻛﻮﻓﻴﺪ‬:‫ﺍﻻﺳﺘﻨﺘﺎﺟﺎﺕ‬ ‫ ﻓﺈﻥ ﺗﺄﺛﻴﺮﻩ ﻋﻠﻰ ﻧﺘﺎﺋﺞ‬،‫ ﻭﻣﻊ ﺫﻟﻚ‬.‫ﺑﺎﻟﺘﻨﺎﻗﺺ ﻓﻰ ﻣﺴﺘﻮﻳﺎﺕ ﺍﻟﺒﺮﻭﺗﻴﻦ ﺍﻟﻤﺘﻔﺎﻋﻞ ﺳﻲ‬ .‫ﺍﻟﻤﺮﺿﻰ ﻟﻢ ﻳﻜﻦ ﻣﻠﺤﻮﻇﺎ‬ ‫؛ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ؛ ﺗﻨﺒﻴﺐ؛ ﻣﻌﺪﻝ ﺍﻟﻮﻓﻴﺎﺕ؛ ﺍﻟﻌﻼﺝ‬19-‫ ﻛﻮﻓﻴﺪ‬:‫ﺍﻟﻜﻠﻤﺎﺕ..